Jatin Vyas, PhD, MD

In the final installment of the short series around fungal infections, Jatin Vyas, PhD, MD, discusses the challenges of developing antifungals.

In the second installment of the short series around fungal infections, Jatin Vyas, PhD, MD, discusses the increase in Candida auris including its unique clades and past challenges in diagnosing this difficult-to-treat infection.

Jatin Vyas, PhD, MD, discusses where the research is headed as it takes a page from the oncology world in trying to harness the immune system and combining with fungal therapeutics to treat these difficult infections.

Jatin Vyas, PhD, MD, offers some insights into the economics of development, the biology of fungal species, and the difficulties behind creating new antifungal molecules.